FDA will allow observational studies as part of a push for real world evidence, new framework says
The FDA on Thursday unveiled a new framework discussing how the agency will use real-world evidence (RWE) and real-world data (RWD) to help companies …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
